Nantes, France

Cécilia Menciu

This inventor holds 2 USPTO granted patents. Top assignees: Asta Medica Aktiengesellschgt, Asta Medica, Aktiengesellschaft. Active years: 1999-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cécilia Menciu. Retrieved from https://idiyas.com/inventor/cecilia-menciu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1999-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Cécilia Menciu: Innovator in Pharmaceutical Chemistry

Introduction

Cécilia Menciu is a notable inventor based in Nantes, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications.

Latest Patents

Menciu holds a patent for N-substituted indole-3-glyoxylamides, which exhibit anti-asthmatic, antiallergic, and immunosuppressant/immunomodulating actions. This invention relates to novel compounds, processes for their preparation, and their pharmaceutical use. The compounds developed by Menciu have the potential to address critical health issues related to asthma and allergies.

Career Highlights

Cécilia Menciu is associated with Asta Medica, Aktiengesellschaft, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions in the pharmaceutical industry.

Collaborations

Menciu has collaborated with notable colleagues, including Guillaume Lebaut and Bernhard Kutscher. These partnerships have enhanced the scope and impact of his research.

Conclusion

Cécilia Menciu's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key figure in the development of therapeutic compounds. His work continues to influence the field and offers promising solutions for health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…